310 related articles for article (PubMed ID: 12466140)
1. Improved contractile function of the mdx dystrophic mouse diaphragm muscle after insulin-like growth factor-I administration.
Gregorevic P; Plant DR; Leeding KS; Bach LA; Lynch GS
Am J Pathol; 2002 Dec; 161(6):2263-72. PubMed ID: 12466140
[TBL] [Abstract][Full Text] [Related]
2. Systemic administration of IGF-I enhances oxidative status and reduces contraction-induced injury in skeletal muscles of mdx dystrophic mice.
Schertzer JD; Ryall JG; Lynch GS
Am J Physiol Endocrinol Metab; 2006 Sep; 291(3):E499-505. PubMed ID: 16621899
[TBL] [Abstract][Full Text] [Related]
3. Administration of insulin-like growth factor-I improves fatigue resistance of skeletal muscles from dystrophic mdx mice.
Gregorevic P; Plant DR; Lynch GS
Muscle Nerve; 2004 Sep; 30(3):295-304. PubMed ID: 15318340
[TBL] [Abstract][Full Text] [Related]
4. Insulin-like growth factor-I analogue protects muscles of dystrophic mdx mice from contraction-mediated damage.
Gehrig SM; Ryall JG; Schertzer JD; Lynch GS
Exp Physiol; 2008 Nov; 93(11):1190-8. PubMed ID: 18567600
[TBL] [Abstract][Full Text] [Related]
5. IGF-I treatment improves the functional properties of fast- and slow-twitch skeletal muscles from dystrophic mice.
Lynch GS; Cuffe SA; Plant DR; Gregorevic P
Neuromuscul Disord; 2001 Apr; 11(3):260-8. PubMed ID: 11297941
[TBL] [Abstract][Full Text] [Related]
6. Contractile efficiency of dystrophic mdx mouse muscle: in vivo and ex vivo assessment of adaptation to exercise of functional end points.
Capogrosso RF; Mantuano P; Cozzoli A; Sanarica F; Massari AM; Conte E; Fonzino A; Giustino A; Rolland JF; Quaranta A; De Bellis M; Camerino GM; Grange RW; De Luca A
J Appl Physiol (1985); 2017 Apr; 122(4):828-843. PubMed ID: 28057817
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic potential of PEGylated insulin-like growth factor I for skeletal muscle disease evaluated in two murine models of muscular dystrophy.
Gehrig SM; van der Poel C; Hoeflich A; Naim T; Lynch GS; Metzger F
Growth Horm IGF Res; 2012 Apr; 22(2):69-75. PubMed ID: 22424862
[TBL] [Abstract][Full Text] [Related]
8. Modulation of insulin-like growth factor (IGF)-I and IGF-binding protein interactions enhances skeletal muscle regeneration and ameliorates the dystrophic pathology in mdx mice.
Schertzer JD; Gehrig SM; Ryall JG; Lynch GS
Am J Pathol; 2007 Oct; 171(4):1180-8. PubMed ID: 17823291
[TBL] [Abstract][Full Text] [Related]
9. Alterations in Notch signalling in skeletal muscles from mdx and dko dystrophic mice and patients with Duchenne muscular dystrophy.
Church JE; Trieu J; Chee A; Naim T; Gehrig SM; Lamon S; Angelini C; Russell AP; Lynch GS
Exp Physiol; 2014 Apr; 99(4):675-87. PubMed ID: 24443351
[TBL] [Abstract][Full Text] [Related]
10. Enhanced dystrophic progression in mdx mice by exercise and beneficial effects of taurine and insulin-like growth factor-1.
De Luca A; Pierno S; Liantonio A; Cetrone M; Camerino C; Fraysse B; Mirabella M; Servidei S; Rüegg UT; Conte Camerino D
J Pharmacol Exp Ther; 2003 Jan; 304(1):453-63. PubMed ID: 12490622
[TBL] [Abstract][Full Text] [Related]
11. Validation of ultrasonography for non-invasive assessment of diaphragm function in muscular dystrophy.
Whitehead NP; Bible KL; Kim MJ; Odom GL; Adams ME; Froehner SC
J Physiol; 2016 Dec; 594(24):7215-7227. PubMed ID: 27570057
[TBL] [Abstract][Full Text] [Related]
12. Sildenafil reduces respiratory muscle weakness and fibrosis in the mdx mouse model of Duchenne muscular dystrophy.
Percival JM; Whitehead NP; Adams ME; Adamo CM; Beavo JA; Froehner SC
J Pathol; 2012 Sep; 228(1):77-87. PubMed ID: 22653783
[TBL] [Abstract][Full Text] [Related]
13. Differential expression of muscular dystrophy in diaphragm versus hindlimb muscles of mdx mice.
Dupont-Versteegden EE; McCarter RJ
Muscle Nerve; 1992 Oct; 15(10):1105-10. PubMed ID: 1406767
[TBL] [Abstract][Full Text] [Related]
14. Muscle-specific overexpression of IGF-I improves E-C coupling in skeletal muscle fibers from dystrophic mdx mice.
Schertzer JD; van der Poel C; Shavlakadze T; Grounds MD; Lynch GS
Am J Physiol Cell Physiol; 2008 Jan; 294(1):C161-8. PubMed ID: 17989207
[TBL] [Abstract][Full Text] [Related]
15. Inspiratory pressure-generating capacity is preserved during ventilatory and non-ventilatory behaviours in young dystrophic mdx mice despite profound diaphragm muscle weakness.
Burns DP; Murphy KH; Lucking EF; O'Halloran KD
J Physiol; 2019 Feb; 597(3):831-848. PubMed ID: 30570134
[TBL] [Abstract][Full Text] [Related]
16. Combined XIL-6R and urocortin-2 treatment restores MDX diaphragm muscle force.
Manning J; Buckley MM; O'Halloran KD; O'Malley D
Muscle Nerve; 2017 Dec; 56(6):E134-E140. PubMed ID: 28294390
[TBL] [Abstract][Full Text] [Related]
17. Leukemia inhibitory factor ameliorates muscle fiber degeneration in the mdx mouse.
Austin L; Bower JJ; Bennett TM; Lynch GS; Kapsa R; White JD; Barnard W; Gregorevic P; Byrne E
Muscle Nerve; 2000 Nov; 23(11):1700-5. PubMed ID: 11054748
[TBL] [Abstract][Full Text] [Related]
18. Force and power output of diaphragm muscle strips from mdx and control mice after clenbuterol treatment.
Lynch GS; Hinkle RT; Faulkner JA
Neuromuscul Disord; 2001 Mar; 11(2):192-6. PubMed ID: 11257477
[TBL] [Abstract][Full Text] [Related]
19. IGF-II ameliorates the dystrophic phenotype and coordinately down-regulates programmed cell death.
Smith J; Goldsmith C; Ward A; LeDieu R
Cell Death Differ; 2000 Nov; 7(11):1109-18. PubMed ID: 11139285
[TBL] [Abstract][Full Text] [Related]
20. Voluntary exercise decreases progression of muscular dystrophy in diaphragm of mdx mice.
Dupont-Versteegden EE; McCarter RJ; Katz MS
J Appl Physiol (1985); 1994 Oct; 77(4):1736-41. PubMed ID: 7836193
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
